Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1038/KI.2009.168 | ||||
| Año | 2009 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Pathological classifications in current use for the assessment of glomerular disease have been typically opinion-based and built on the expert assumptions of renal pathologists about lesions historically thought to be relevant to prognosis. Here we develop a unique approach for the pathological classification of a glomerular disease, IgA nephropathy, in which renal pathologists first undertook extensive iterative work to define pathologic variables with acceptable inter-observer reproducibility. Where groups of such features closely correlated, variables were further selected on the basis of least susceptibility to sampling error and ease of scoring in routine practice. This process identified six pathologic variables that could then be used to interrogate prognostic significance independent of the clinical data in IgA nephropathy (described in the accompanying article). These variables were (1) mesangial cellularity score; percentage of glomeruli showing (2) segmental sclerosis, (3) endocapillary hypercellularity, or (4) cellular/fibrocellular crescents; (5) percentage of interstitial fibrosis/tubular atrophy; and finally (6) arteriosclerosis score. Results for interobserver reproducibility of individual pathological features are likely applicable to other glomerulonephritides, but it is not known if the correlations between variables depend on the specific type of glomerular pathobiology. Variables identified in this study withstood rigorous pathology review and statistical testing and we recommend that they become a necessary part of pathology reports for IgA nephropathy. Our methodology, translating a strong evidence-based dataset into a working format, is a model for developing classifications of other types of renal disease.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Roberts, Ian S. D. | Hombre |
John Radcliffe Hosp - Reino Unido
John Radcliffe Hospital - Reino Unido |
| 2 | Cook, H. Terence | - |
Univ London Imperial Coll Sci Technol & Med - Reino Unido
Imperial College London - Reino Unido |
| 3 | Troyanov, Stephan | Hombre |
UNIV MONTREAL - Canadá
Hôpital du Sacré-Coeur de Montréal - Canadá Hôpital du Sacré-Cœur-de-Montréal - Canadá |
| 4 | Alpers, Charles E. | Hombre |
UNIV WASHINGTON - Estados Unidos
University of Washington Medical Center - Estados Unidos |
| 5 | Amore, Alessandro | Hombre |
Univ Turin - Italia
Università degli Studi di Torino - Italia |
| 6 | Barratt, J. | Hombre |
Leicester Gen Hosp - Reino Unido
Leicester General Hospital - Reino Unido |
| 7 | Berthoux, Francois | - |
CHU St Etienne - Francia
Hôpital Nord CHU de Sainte-Etienne - Francia |
| 8 | Bonsib, Stephen | Hombre |
LSU Hlth Sci Ctr - Estados Unidos
LSU Health Sciences Center - Shreveport - Estados Unidos |
| 9 | Bruijn, Jan A. | Hombre |
Leiden Univ - Países Bajos
Leiden University Medical Center - LUMC - Países Bajos Leids Universitair Medisch Centrum - Países Bajos |
| 10 | Cattran, Daniel C. | Hombre |
Toronto Gen Res Inst - Canadá
Toronto General Research Institute University of Toronto - Canadá Toronto General Hospital Research Institute - Canadá |
| 11 | Coppo, Rosanna | Mujer |
Univ Turin - Italia
Università degli Studi di Torino - Italia |
| 12 | D'Agati, Vivette | Mujer |
Columbia Univ Coll Phys & Surg - Estados Unidos
Vagelos College of Physicians and Surgeons - Estados Unidos |
| 13 | D'Amico, Giuseppe | Hombre |
Fdn DAmico Ric Malattie Renali - Italia
Fondazione D'Amico per la Ricerca sulle Malattie Renali - Italia |
| 14 | Emancipator, Steven N. | Hombre |
Case Western Reserve Univ - Estados Unidos
Case Western Reserve University - Estados Unidos |
| 15 | Emma, F. | Hombre |
Bambino Gesu Childrens Hosp & Res Inst - Italia
Children's Hospital - Italia |
| 16 | Feehally, John | Hombre |
Leicester Gen Hosp - Reino Unido
Leicester General Hospital - Reino Unido |
| 17 | Ferrario, Franco | Hombre |
San Carlo Borromeo Hosp - Italia
Azienda Ospedaliera San Carlo Borromeo - Italia |
| 18 | Fervenza, F. C. | Hombre |
Mayo Clin - Estados Unidos
Mayo Clinic - Estados Unidos |
| 19 | Florquin, Sandrine | Mujer |
Univ Amsterdam - Países Bajos
Universiteit van Amsterdam - Países Bajos |
| 20 | Fogo, Agnes B. | Mujer |
Vanderbilt Univ - Estados Unidos
Vanderbilt University - Estados Unidos |
| 21 | Geddes, Colin | Hombre |
Univ Glasgow - Reino Unido
Western Infirmary - Reino Unido |
| 22 | Groene, Hermann-Josef | Hombre |
German Canc Res Ctr - Alemania
German Cancer Research Center - Alemania |
| 23 | Haas, Mark | Hombre |
Johns Hopkins Univ - Estados Unidos
Johns Hopkins School of Medicine - Estados Unidos |
| 24 | Herzenberg, Andrew M. | Hombre |
Univ Hlth Network - Canadá
UNIV TORONTO - Canadá University Health Network University of Toronto - Canadá |
| 25 | Hill, Prue A. | - |
St Vincents Hosp - Australia
St. Vincent's Hospital Melbourne - Australia |
| 26 | Hogg, Ronald J. | Hombre |
Scott & White Med Ctr - Estados Unidos
Scott and White - Estados Unidos |
| 27 | Hsu, Stephen I. | Hombre |
UNIV FLORIDA - Estados Unidos
University of Florida - Estados Unidos |
| 28 | Jennette, J. Charles | - |
UNIV N CAROLINA - Estados Unidos
The University of North Carolina at Chapel Hill - Estados Unidos |
| 29 | Joh, Kensuke | Hombre |
E Natl Hosp - Japón
National Cancer Hospital East - Japón National Hospital Organization Chiba-East National Hospital - Japón |
| 30 | Julian, Bruce A. | Hombre |
UNIV ALABAMA - Estados Unidos
The University of Alabama at Birmingham - Estados Unidos |
| 31 | Kawamura, Tetsuya | Hombre |
Jikei Univ - Japón
The Jikei University School of Meidicine - Japón The Jikei University School of Medicine - Japón |
| 32 | Lai, Fernand M. | Hombre |
Chinese Univ Hong Kong - China
Chinese University of Hong Kong - Hong Kong |
| 33 | Li, Lei-Shi | - |
Nanjing Univ - China
Medical School of Nanjing University - China |
| 34 | Li, Philip K. | Hombre |
Chinese Univ Hong Kong - China
Prince of Wales Hospital Hong Kong - Hong Kong Chinese University of Hong Kong - China |
| 35 | Liu, Zhi Hong | - |
Medical School of Nanjing University - China
Nanjing Univ - China |
| 35 | Liu, Zhi-Hong | - |
Nanjing Univ - China
|
| 36 | Mackinnon, Bruce | Hombre |
Univ Glasgow - Reino Unido
Western Infirmary - Reino Unido |
| 37 | MEZZANO-ABEDRAPO, SERGIO AGUSTIN | Hombre |
Universidad Austral de Chile - Chile
|
| 38 | Schena, F. Paolo | - |
Policlin - Italia
Renal - Italia Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari - Italia |
| 39 | Zhang, Long | Hombre |
Juntendo Univ - Japón
Juntendo University School of Medicine - Japón |
| 40 | Walker, Patrick D. | Hombre |
Nephropathol Associates - Estados Unidos
Nephropathology Associates - Estados Unidos |
| 41 | Wang, Haiyan | - |
Peking Univ - China
Peking University First Hospital - China |
| 42 | Weening, Jan J. | Hombre |
Erasmus MC - Países Bajos
|
| 43 | Yoshikawa, Nori | Mujer |
Wakayama Med Univ - Japón
Wakayama Medical University - Japón |
| 44 | DE ALBUQUERQUE MARANHAO-CARNEIRO, LETICIA | Mujer |
Peking Univ - China
Peking University First Hospital - China |
| 45 | Int igA Nephropathy Network | Corporación | |
| 46 | Renal Pathol Soc | Corporación |
| Fuente |
|---|
| Vifor Aspreva Pharma |
| International Society of Nephrology, Kidney Research UK |
| Vifor Pharma |
| Agradecimiento |
|---|
| The work was supported by an unrestricted educational grant from Vifor Aspreva Pharma. The Working Group acknowledges the generous support of the International Society of Nephrology, Kidney Research UK, and Vifor Pharma Aspreva. |
| The work was supported by an unrestricted educational grant from Vifor Aspreva Pharma. The Working Group acknowledges the generous support of the International Society of Nephrology, Kidney Research UK, and Vifor Pharma Aspreva. |